Join to View Full Profile
1515 Holcombe BlvdHouston, TX 77030
Phone+1 713-792-6161
Dr. Markman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
NYU Grossman School of MedicineResidency, Internal Medicine, 1974 - 1978- New York University School of MedicineClass of 1974
Johns Hopkins UniversityFellowship, Hematology and Medical Oncology
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology
Certifications & Licensure
CA State Medical License 2002 - Present
PA State Medical License 2001 - 2026
GA State Medical License 2012 - 2015
TX State Medical License 2006 - 2012
MI State Medical License 2002 - 2006
OH State Medical License 1992 - 2006
IL State Medical License 2002 - 2005
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
- Join now to see all
Awards, Honors, & Recognition
- Fellow (FASCO) American Society of Clinical Oncologists, 2011
Clinical Trials
- S9701 Paclitaxel in Treating Patients With Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in Remission Start of enrollment: 1997 Nov 01
- Weekly Infusions of Paclitaxel in Treating Women With Stage III or Stage IV Ovarian Cancer Refractory to Paclitaxel and Platinum Start of enrollment: 1997 Sep 01
- Paclitaxel in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer Start of enrollment: 2001 Jul 01
- Join now to see all
Publications & Presentations
PubMed
- 5 citationsWhat proportion of patients with stage 3 ovarian cancer are potentially cured following intraperitoneal chemotherapy? Analysis of the long term (≥10 years) survivors i...Omali Pitiyarachchi, Michael Friedlander, James J Java, John K Chan, Deborah K Armstrong
Gynecologic Oncology. 2022-09-01 - 18 citationsDifferences in presentation and survival of Asians compared to Caucasians with ovarian cancer: An NRG Oncology/GOG Ancillary study of 7914 patients.Katherine Fuh, James J. Java, John K. Chan, Daniel S. Kapp, Bradley J. Monk
Gynecologic Oncology. 2019-08-01 - 9 citationsPharmaceutical Management of Ovarian Cancer: Current Status.Maurie Markman
Drugs. 2019-07-01
Other
- Intraperitoneal chemotherapy for treatment of ovarian cancerMarkman M, Walker JL
http://www.uptodate.com/contents/intraperitoneal-chemotherapy-for-treatment-of-ovarian-cancer
UpToDate, Wolters Kluwer Health - 2012-06-14
Press Mentions
Critical Data on Breast Cancer Rates and MortalityMarch 25th, 2025- Projected Cancer Trends Highlight Urgent Need for PreventionMarch 17th, 2025
- Real-World Data Shows Promise for Advanced Melanoma PatientsMarch 12th, 2025
- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
